Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous, persistent environmental contaminants, of which 16 are EPA-designated priority pollutants.
cardiac sensitivity to developmental PAH exposures and have implications for the cardiovascular health of PAH-exposed humans and wild amphibians.
Introduction
Polycyclic aromatic hydrocarbons (PAHs) are a large group of ubiquitous and persistent pollutants that continue to be deposited into the environment primarily with the incomplete combustion of fossil fuels among other sources (Agency for Toxic Substances and Disease Registry (ATSDR), 1995). The Environmental Protection Agency (EPA) has designated 16 PAHs as priority pollutants. These include the four PAHs under investigation here: the tricyclic AH phenanthrene (PHE), the tetracyclic AHs pyrene (PYR) and fluoranthene (FLA), and the fiveringed benzo-(a)-pyrene (BaP) ( Table 1 ). In contrast to BaP, a well-studied carcinogen, PHE, PYR and FLA toxicity remains poorly characterized and their inclusion as priority pollutants is primarily due to their prevalence in the environment.
Crude oil spills, most notably the Deepwater Horizon disaster in the Gulf of Mexico (2010) , generated multiple investigations into the impact of PAH exposure on developing fish and fish populations and the resulting economic implications. It is now well-established that early exposure to select polycyclic aromatic hydrocarbons (PAHs), either as single compounds or as components of weathered crude oil, leads to abnormal cardiac morphology and function in fish.
These studies also revealed diversity in modes of action and tissue specificity for single PAHs. For example, in zebrafish (Danio rerio), cardiotoxicity associated with developmental exposure to PHE is independent of the AHR (aryl hydrocarbon receptor) and CYP1A (cytochrome P450 type 1A) activity (Incardona et al., 2005) , while BaP-induced cardiotoxicity is both AHR and CYP1A-dependent Incardona et al., 2011) . While there is little cardiotoxicity associated with PYR exposure, it is reported to cause AHRand CYP1A-dependent perturbations in the form of anemia, peripheral vascular defects, and neuronal cell death in the early life stages of zebrafish (Incardona et al., 2004; Zhang et al., 2012) . In contrast, FLA is an inhibitor of CYP1A activity in fish and, as a single compound, yet to be associated with abnormal cardiac function or morphology. Collectively, these studies underscore the diversity in target tissues and mechanism of toxicity among individual PAHs.
The embryos and larvae of the African clawed frog Xenopus laevis are important models for investigating normal vertebrate heart development, providing insight, for example, into human congenital heart defects (Kolker et al., 2000; Mohun et al., 2000; Warkman and Krieg, 2007) . Xenopus also serves as a tractable model amphibian for identifying potential environmental impacts on amphibian species in general, an important attribute in the face of global decline in amphibian populations (Adams et al., 2013; Grant et al., 2016) . Finally, Xenopus embryos and larvae provide an attractive system for investigating mechanisms of developmental toxicity with PAH exposure because, in comparison to fish and even rodent models, the sensitivity of their AHR system to certain AHR agonists (e.g. dioxin) is greatly reduced and more closely mirrors that of humans and other amphibians (Lavine et al., 2005; Silkworth et al., 2005; Zimmermann et al., 2008) .
Humans are typically exposed to PHE, PYR, and FLA and other PAHs through the ingestion of contaminated food and the inhalation of polluted air (Marti-Cid et al., 2008; Narváez et al., 2008) . Other factors include proximity to industrial and urban settings, smoking and work-related exposure (Agency for Toxic Substances and Disease Registry (ATSDR), 1995; Jung et al., 2010; Williams et al., 2012) . In addition, the use of biomass cookstoves in poorly ventilated shelters represents a significant route of exposure for a large proportion of the world population (Gadi et al., 2012; Riojas-Rodriguez et al., 2011) .
For a variety of reasons, children bear a higher PAH burden than do adults (Perera, 2008) . Furthermore, there is evidence for significant placental transfer of PHE, PYR, and FLA in humans. Indeed, PHE, PYR, and FLA are among the top five most abundant priority PAHs detected in human placenta, cord blood and milk, underscoring the need to investigate their potential for developmental risk (Tsang et al., 2011; Yu et al., 2011) . In contrast, BaP was undetectable in human milk, maternal and cord serum in one of these studies (Tsang et al., 2011 ) and present at much lower levels than PHE, PYR and FLA in the other.
Wild larval amphibians are exposed to PAHs through contamination of their aquatic environments by oil spills, contaminated sediments, and with proximity to roadways and industrial settings (Bradford et al., 2010; Garrigues et al., 2004) . In particular, runoff from roadways and other paved surfaces that have been sealed with coal tar-based sealants represents a significant PAH source for watersheds particularly as the road or parking lot surface is degraded over time with vehicular use and weather conditions . It should be noted that coal tar sealant dust has likewise emerged as a concerning source of PAH exposure in children particularly in urban areas .
There are few additional studies that have focused on the developmental effects of exposure to single PAHs to corroborate their distinct modes of action and tissue-or species-specificity. Understanding the selective developmental impacts and the underlying mechanisms by which different individual PAHs adversely alter development is critical to the accurate assessment of the risk of exposure to both humans and wildlife. To extend current understanding of the mechanism(s) of toxicity for these prevalent priority PAHs, we compared the impact of early exposure to the common pollutants PHE, PYR, FLA, and BaP on cardiac function and cyp1a mRNA expression using a model system in which sensitivity to AHR agonists is particularly low, providing a useful contrast to findings derived from fish studies. We predicted that, in comparison to fish, Xenopus hearts would be equally sensitive to PHE since its actions are AHR-and CYP1A-independent, but far less sensitive to BaP as its cardiotoxic effects are mediated by the AHR and CYP1A. In addition, we predicted that it would be unlikely that early exposure to FLA, a CYP1A inhibitor, or to PYR, only a moderate AHR agonist, would result in any negative impacts on cardiac function in Xenopus. Embryo exposure protocol We chose a range of doses similar to those used in several fish studies (0.25 -25 µM for PHE, FLA, and PYR and 0.5 -5 µM for BaP) to facilitate comparison and determination of species-specific effects (see Table 1 for doses in ppm). Stock solutions of fluoranthene, benzo(a)pyrene, pyrene, and phenanthrene (>96-99% purity, Sigma Aldrich) were prepared in 100% dimethyl sulfoxide (DMSO, Sigma Aldrich) and stored at -20 o C. All other reagents were obtained from Sigma Aldrich unless otherwise noted. Treatments consisted of dilutions of the stocks with 10% HF to achieve final concentrations.
Materials and Methods

Animal husbandry and embryo manipulation
The experiment was replicated using 6 different broods of embryos (resulting from 6 different matings) and included age-matched, untreated, vehicle (0.02-0.04% DMSO) controls. We previously established that vehicle controls did not differ from 10% HF controls. 10 embryos from each brood were randomly assigned to the vehicle control or one of the 11 PAH treatment groups and housed in glass scintillation vials at a density of 1.5 mL/embryo at 22 Heart rate and atrioventicular block Animals were exposed to either 0.25, 2.5 or 25 µM PHE, PYR or FLA or to 0.5 or 5 µM BaP for the time periods indicated below and their heart rates (HR) and incidence of atrioventricular (AV) block compared to animals exposed to 0.02% DMSO (vehicle or negative control (Fujita, 1999) , and ornithine decarboxylase (odc1, endogenous control) mRNA (Sindelka et al., 2006) . As a pseudotetraploid, Xenopus laevis possesses two cyp1a genes (Lavine et al., 2005) . Primer and probe sequences are provided in Table 2 . Samples were analyzed without reverse transcriptase as a control for genomic DNA contamination and without template DNA to control for reagent contamination. All gene expression assays were demonstrated to amplify a single product of expected size and with equal efficiency over a range of RNA concentrations (Bustin et al., 2009) .
Statistics Statistical significance (p ≤ 0.05) was determined using one-way analysis of variance (ANOVA) followed by Dunnett's multiple comparisons test (GraphPad™ Prism 6.0, GraphPad Software, San Diego). The results of the gene expression studies were analyzed using the 2 -ΔΔCT method (Livak and Schmittgen, 2001 ) and expressed as fold increases over vehicle (0.02% DMSO) control mRNA levels.
Results
Mortality and Developmental Abnormalities
Overall, few developmental abnormalities were noted following 96 h PAH treatments (Table 3 ) and those few were typically mild, not severe, in nature. The most common abnormality, craniofacial defects, occurred in 7% of embryos exposed to B(a)P (0.5 and 5 µM)
and FLA (25 µM). Edema was rarely observed. There was only a single observation of pericardial edema (with 0.25 µM PYR).
There was no evidence of developmental delay or advancement with PAH exposure; however, embryos exposed to 0.25 and 2.5 µM PHE had greater snout-to-vent lengths (p< 0.05) than those of vehicle controls (data not shown).
No other differences in snout-to-vent lengths were observed. Finally, it was noted that animals exposed to 25 µM PHE, FLA, and PYR were overall much lighter in appearance with punctate, not dendritic, ventral melanophores.
Survival rates did not differ between PAH-treated and vehicle control animals at day 5 of exposure, but by day 8, the majority of animals exposed continuously to 2.5 and 25 µM PYR, 25 µM PHE and 25 µM FLA had died (Figure 1 ). This pattern remained until the end of the experiment at day 10. In contrast, the survival rates of animals exposed to the lower doses of FLA and PHE and to BaP did not differ from controls over the 10-day period.
Heart rate Ventricular rates for X. laevis embryos increased steadily with heart development (Figure 2) , from a mean of 57 bpm for NF stage 37 DMSO we did observe with PHE, but not with FLA treatment, several instances of AV delay, where a one: one correspondence between atrial and ventricular contractions was maintained, but the time between the atrial and ventricular contractions (A:V interval) was obviously increased (data not shown).
Atrioventricular Block Increased incidence of atrioventricular (AV) block,
where the number of atrial contractions exceeded the number of ventricular contractions for a 20 s period (Table 4) , was typically observed with PAH exposure and never observed for vehicle controls or with 0.5 µM B(a)P. The highest incidence (45% at stage 46/47) was noted for animals exposed to 25 µM FLA. Complete AV block ("ventricular standstill") for the full 20 s period was observed with FLA, PYR and PHE exposure, but never with exposure to B(a)P.
cyp1A mRNA levels Changes in mRNA levels for the two cyp1a genes (cyp1a6 and cyp1a7), following 72 h PAH treatment, were expressed as fold differences from DMSO control levels. In general, the cyp1a6 paralog was less sensitive to PAH induction than was cyp1a7, with the exception of the highest dose of PHE (25 µM) which was associated with a 15-fold increase in cyp1a6, but no effect on cyp1a7, expression. As expected, the classic AHR agonist BaP (5 µM) was a potent inducer of cyp1a (~60-fold for cyp1a7) expression.
Surprisingly, FLA, an inhibitor of cyp1a expression in zebrafish, was found to be an AHR activator (at 25 µM) in Xenopus embryos, as evidenced by a 35-fold increase in cyp1a7 expression.
Discussion
As the first organ to develop and due to its critical role in establishing the circulation, the heart serves as an important endpoint of developmental toxicity.
Most, if not all, previous studies investigating the cardiotoxic potential of single
PAHs used fish models. For two reasons, we chose to study PAH-induced cardiotoxicity in Xenopus laevis tadpoles. Xenopus hearts have three, not two, chambers and are more similar in structure and function to human hearts. The embryos and larvae of the African clawed frog Xenopus laevis have long served as important models for investigating normal vertebrate heart development (Kolker et al., 2000; Mohun et al., 2000; Warkman and Krieg, 2007) .
Furthermore, fish and frogs differ in their relative sensitivities to contaminants that exert their toxicity through the binding and activation of the aryl hydrocarbon receptor (AHR). In comparison to frogs and other vertebrate models, fish possess a more complex AHR system. Due to gene and genome duplication events, fish possess two AHR clades, AHR1 and AHR2, and three AHR genes (ahr1a, ahr1b, and ahr2) (Hahn ME et al., 2006; Incardona et al., 2011) .
Importantly, the sensitivity of fish to AHR agonists, like dioxin, is far greater than what has been observed for many other vertebrates, including humans, complicating the ability to extrapolate the results of PAH toxicity studies to other species. In contrast, the early life stages of Xenopus laevis provide an attractive system for investigating the developmental impacts of PAH exposure because, in comparison to fish and even rodent models, the sensitivity of their AHR system to certain AHR agonists (e.g. dioxin) is greatly reduced and more closely mirrors that of humans and other amphibians (Lavine et al., 2005; Silkworth et al., 2005; Zimmermann et al., 2008) . Comparing the responses to developmental exposures of single PAHs between two important model systems that vary greatly in their degree of AHR sensitivity could reveal valuable information about mechanism(s) of PAH cardiotoxicity.
Despite differences in heart morphology, the progression of heart development, including the timing of cardiac looping (by 36 hpf) and valve formation (72 hpf), is very similar for Xenopus laevis and zebrafish (Danio rerio) allowing for ready comparison of PAH-induced cardiotoxicity between species. Like zebrafish embryos, Xenopus embryos and larvae are transparent, allowing one to observe for abnormalities in cardiac function. As with zebrafish (Danio rerio), Xenopus embryos can rely on diffusion alone until day 7-8 of development (Burggren, 2004) which includes the entire period of heart development. Indeed, despite the presence of gross cardiac abnormalities, the lethal effects of PAH-induced cardiotoxicity in zebrafish do not manifest until day 7 when diffusion becomes limiting (Incardona et al., 2006) . Our survival data support this as the case for the early life stages of Xenopus as well, as no increase in PAH-induced mortality was observed until day 8 of development ( Figure 1 ).
To varying degree, exposure to all of the PAHs under investigation here disrupted the normal pacemaker activity of Xenopus embryos and/or larvae at some point during the period of heart development ( Figure 2 ). Only the highest dose of FLA (25 μM) increased HR after 48 h of exposure (stage 37, during atrioventricular partitioning and immediately following cardiac looping). In contrast, by NF stage 42 (during atrial partitioning, 72 hpe), embryos exposed to PYR, PHE, or FLA at 0.25-25 μM or to BaP at 5 μM exhibited ventricular tachycardia (increased heart rate). Interestingly, these PAH-induced increases in HR were not dose-dependent, an indication that heart rates may have been at their maximum. In general, PAH-induced tachycardia persisted into stage 45
(valve formation, 96 hpe) for all but the highest doses of PHE and FLA which did not differ from controls. As development progressed, ventricular tachycardia was no longer observed with exposure to any of the PAHs (mature heart phenotype, stage 46/47,120 hpe). However, larvae exposed to FLA at 25 μM exhibited bradycardia (reduced HR).
Atrial beating rates (Figure 2 ) typically mirrored the PAH-induced responses observed for ventricular rates with one notable exception. At stage 46/47, atrial tachycardia was associated with FLA exposure at 2.5 and 25 μM, yet ventricular bradycardia was observed 25 μM, indicating that FLA interferes with normal cardiac conduction in a dose-dependent manner. In general, PAH exposure was associated with increased incidence of atrioventricular (AV) block, as assessed by the difference in atrial and ventricular beating rates, in a dose-dependent manner (Table 4) , ranging from 19 -45% of animals exhibiting AV block with exposure to the highest doses of PYR, PHE, and FLA. The predominant form of AV block observed was 2:1 AV block (two atrial contractions for every ventricular contraction) with some individuals in ventricular standstill for the entire 20 s period. Instances of AV block were noted with BaP exposure but to a lesser degree than for the other PAHs and no BaP-exposed animals exhibited complete block.
In contrast to our results, at 72 hpe, PHE-exposed zebrafish embryos exhibit ventricular bradycardia, not tachycardia, an effect attributed to increased incidence of AV block (Incardona et al., 2005) . Although a longer exposure period (120 h) was required, we did observe a trend toward PHE-induced bradycardia. In the embryos of zebrafish, but not medaka (Oryzias melastigma), BaP induces severe bradycardia (Incardona et al., 2011; Mu et al., 2012 ), a response not observed in Xenopus embryos or larvae.
Studies using fish embryos have not revealed evidence of AV block or compromised cardiac conduction activity with exposures to PYR or FLA, as single compounds, as was observed here with Xenopus. In particular, the degree of disruption of normal pacemaker activity with FLA exposure was surprising, because, to our knowledge, as a single compound, FLA is not reported to alter pacemaker activity in fish embryos. However, AV conduction block has been previously associated with PHE exposure in fish (Incardona et al., 2004) .
Specifically, fish exposed to PHE as a single compound or as a component of weathered crude oil have demonstrated an array of cardiac dysfunctions including bradycardia, reduced contractility, arrhythmias, pericardial edema, and heart failure, effects that can be explained by disruption of normal cardiac conduction.
As predicted, the disruption of normal pacemaker and conduction activity observed with BaP exposure was less impactful than for the other PAHs and certainly in comparison to BaP-induced effects on the early fish heart, which are quite severe. In Xenopus, BaP exposure was associated with atrial and ventricular tachycardia but only at the highest dose, a lower incidence of AV block, no evidence of complete block, and, also in contrast to the other PAHs, no increase in mortality by day 8 (Figure 1 ). And, while BaP exposure was associated with higher incidence of developmental abnormalities in comparison to the other PAHs (Table 3) , the percentage of affected animals remained low.
Only 7% of BaP-exposed animals had craniofacial abnormalities and no edema was observed, in stark contrast to observations with BaP exposure in fish embryos Incardona et al., 2011) . Morpholino studies in fish reveal that BaP-induced developmental abnormalities and cardiotoxicity are dependent on AHR activation and CYP1A induction (Incardona et al., 2011) .
Because the early life stages of Xenopus are known to be resistant to potent AHR agonists like dioxin, a reduced impact on normal cardiac function for BaP was predicted and observed for this study.
Interestingly, the comparatively reduced impact on normal cardiac function seen with BaP exposure was accompanied by the most potent degree of AHR activation of all the PAHs, a 60-fold increase in mRNA levels for cyp1a7, the more BaP-sensitive of the paralogs (Figure 3 ). While PHE is not reported to stimulate AHR activity in fish, PHE was associated with a 15-fold increase in cyp1a6 expression in our study. Furthermore, exposure to PYR, purportedly a weak AHR agonist in fish (Incardona et al., 2006) BaP (Van Tiem and Di Giulio, 2011) . We are unable to conclude from this study whether FLA-induced cardiotoxicity is related to CYP1A activity in Xenopus.
In Xenopus, there was no apparent correlation between cardiotoxicity and cyp1a mRNA levels. BaP, arguably the least impactful of normal cardiac function, was the most potent AHR agonist. In addition, significant cardiac impacts were observed with exposure to any of the three other PAHs, but only the highest dose of FLA (25 µM) stimulated cyp1a mRNA expression to any measurable degree.
And, while these findings do not constitute proof, they do not support the idea that the cardiotoxic impacts of PHE or PYR are likely to be AHR-mediated in
Xenopus. There remains the possibility that the AHR plays a mechanistic role in FLA-induced effects on cardiac function in Xenopus, but it is important to recognize that cyp1a mRNA levels are normally extremely low in early life stages of Xenopus (Zimmermann et al., 2008) , making it difficult to predict whether an increase of 35-fold, as seen with 25 µM FLA, is of any physiological relevance.
Based on the results reported here, alternative mechanisms should be explored.
The cardiotoxicity of weathered crude oil, enriched with PHE and other threeringed PAHs, was investigated using electrophysiological and Ca 2+ -imaging techniques on isolated cardiomyocytes obtained from juvenile tuna hearts (Brette et al., 2014 In summary, these results confirm previous studies demonstrating compoundspecific effects on normal pacemaker and conduction activity with early PAH exposure. They also reveal species-specific differences between the PAHinduced cardiotoxic responses of fish and frog, an important contribution since nearly all current studies focus on fish models. Finally, our findings have implications for the normal development of the cardiovascular systems of PAHexposed humans and wild amphibians. Target cDNA (GenBank #) Primer/Probe Sequence cyp1a6 (NM_1172237) F: 5'-GCAGTATTGGCTTAACTCCTGG-3' P: 5'-TGTTGCAAAAGTCTTGGTTCCCCAG-3' R: 5'-CCCTTTCTATTCTCTGCCCTG-3' cyp1a7 (NM_1097072) F: 5'-GTTCTAGTTACTTCCCTGCCC-3' P: 5'-TTGTTTCCCCTTGCACTTTTGGTTCC -3' R: 5'-ATAGTTTGTACATTTGCTCTTGCC-3' odc1 (NM_1086698) F: 5'-CTGTTAGGAGCTTTGTCAGAGG-3' P: 5'-TGGTTATTTGTGGCCTCGATGGGT-3' R: 5'-ACAAGTCCTACGCTCTCAATG-3' F, forward primer; P, probe; R, reverse primer 
